Lv1
14 积分 2024-09-12 加入
First-line atezolizumab monotherapy versus single-agent chemotherapy in patients with non-small-cell lung cancer ineligible for treatment with a platinum-containing regimen (IPSOS): a phase 3, global, multicentre, open-label, randomised controlled study
2个月前
已完结
First-line benmelstobart plus anlotinib versus sunitinib in advanced renal cell carcinoma (ETER100): a multicentre, randomised, open-label, phase 3 trial
2个月前
已完结
CAR T cell therapy for patients with solid tumours: key lessons to learn and unlearn
3个月前
已完结
Axicabtagene ciloleucel in relapsed or refractory indolent non-Hodgkin lymphoma (ZUMA-5): a single-arm, multicentre, phase 2 trial
4个月前
已完结
KTE-X19 for relapsed or refractory adult B-cell acute lymphoblastic leukaemia: phase 2 results of the single-arm, open-label, multicentre ZUMA-3 study
4个月前
已完结
Wearable blood pressure sensors for cardiovascular monitoring and machine learning algorithms for blood pressure estimation
6个月前
已完结
Trends in the development of cellular and gene therapy in China
7个月前
已完结
CAR-T therapy in solid tumors
7个月前
已完结
Rapid manufacturing of CAR-T therapy: strategies and impact
7个月前
已完结
Can high-dose aflibercept satisfy unmet treatment needs in diabetic macular oedema?
8个月前
已完结
皖公网安备34019202002308
